A Genetic Test of a Model for Two Activities of Fushi Tarazu Protein in Drosophila Melanogaster by Briek, Alaa
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
4-19-2016 12:00 AM 
A Genetic Test of a Model for Two Activities of Fushi Tarazu 
Protein in Drosophila Melanogaster 
Alaa Briek 
The University of Western Ontario 
Supervisor 
Dr. Anthony Percival-Smith 
The University of Western Ontario 
Graduate Program in Biology 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Alaa Briek 2016 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Cell Biology Commons, and the Developmental Biology Commons 
Recommended Citation 
Briek, Alaa, "A Genetic Test of a Model for Two Activities of Fushi Tarazu Protein in Drosophila 
Melanogaster" (2016). Electronic Thesis and Dissertation Repository. 3698. 
https://ir.lib.uwo.ca/etd/3698 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
 ii 
Abstract 
The important pair-rule segmentation gene fushi tarazu (ftz) encodes a homeodomain (HD)-
containing protein involved in the establishment of even-numbered parasegments during 
embryonic development. The D. melanogaster ftz is a derived homeotic selector (Hox) gene 
which lost its homeotic function during the evolution of arthropods. Genetic analyses have 
shown that FTZ has two distinct activities required during development: HD-dependent and 
HD-independent FTZ activities. The aim of this study was to test the interaction of the two 
FTZ activities proposed by Hyduk and Percival-Smith (1996), by generating site-specific 
mutant ftz alleles for intragenic complementation. CRISPR-mediated homology directed 
repair (HDR) was used to introduce engineered ftz alleles into the ftz locus. Subsequently, 
four ftz engineered alleles were constructed in vectors for reintroduction by Recombinase-
mediated cassette exchange (RMCE). Despite using multiple approaches no CRISPR 
mediated HDR events were detected, and therefore, the model could not be tested. 
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1 INTRODUCTION  
1.1 Drosophila melanogaster as a model system 
Drosophila melanogaster commonly known as the “fruit fly”, is an attractive model 
system of great interest to researchers in the fields of molecular biology, genetics and 
neuroscience. The powerful genetic tools available for D. melanogaster allow 
investigators to elucidate the basis of complex traits, and gene-gene and gene-
environment interactions. The D. melanogaster genome has been sequenced (Adams et 
al., 2000). In addition, D. melanogaster has a short life cycle, can be easily handled in 
laboratories and females have high fecundity. After fertilization, the egg is laid 
externally, which allows scientists to study its development very closely thereby offering 
a key model of development. How genes control development has been studied in great 
depth in D. melanogaster due to its well-understood cell biology, genetics and genome 
(Rubin, 1988). In addition, research into the genetics of D. melanogaster has been greatly 
assisted by the ability to introduce DNA into the genome. The most used method to 
introduce DNA into flies is P-element mediated transformation (Spradling & Rubin, 
1982; Beall & Rio, 1998; Konev et al., 2003). Over the past ten years, methods for gene 
replacement via homologous recombination (HR) have also been developed (Rong & 
Golic, 2000; Horn & Handler, 2005), but due to the complexity and inefficiencies of the 
procedures, they are not used extensively (Huang et al., 2009). 
1.2 Transgenic techniques used in Drosophila   
1.2.1 P-element-mediated transformation 
The P-element is a Drosophila transposable element that has interested researchers for 
many years (Majumdar & Rio, 2015). They are small transposons that have terminal 31 
base pair (bp) inverted repeats, and generate 8 bp direct repeats of target DNA sequence 
upon insertion (Huang et al., 2009). P-elements are used for mutagenesis and the 
development of genetically modified flies used in genetic research (Venken & Bellen, 
2007). P-element-mediated germ-line transformation is a powerful transgenic tool in 
Drosophila, especially when it is employed as an insertional mutagen or when it is 
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combined with tools such as the GAL4-UAS system (Brand & Perrimon, 1993). One 
important characteristic of P-elements is the random site of integration into the genome. 
Although the random nature of P-element integration is vital for generating insertion 
mutations and deletions (indels), it is not ideal for generating transgenic flies. The 
random integration of P-elements requires substantial efforts to map the site of insertion, 
and the genomic position of the insertion can influence the expression of the transgene 
thereby requiring analysis of multiple insertion lines to ensure that the alteration in 
phenotype is due to exclusively transgene expression and not an insertion artifact. 
Another disadvantage of the P-element system is its variable transformation 
effectiveness, a serious problem for large-scale transgenesis efforts (Bateman et al., 
2006). Numerous strategies have been developed to overcome this issue of random 
insertion of transposons using systems based on the FLP and Cre recombinases (Siegal & 
Hartl, 1996; Venken & Bellen, 2007). These solutions allow precise targeting to genomic 
landing site, bypassing the need to analyze multiple independent insertions (Bateman et 
al., 2006). 
1.2.2 TALENs and Zinc-finger nucleases 
Zinc-finger Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases 
(TALENs) are important tools in modern biological research (Gaj et al., 2013). These 
chimeric nucleases are composed of programmable, sequence-specific DNA-binding 
components associated with a general DNA cleavage domain. ZFNs and TALENs allow 
a comprehensive variety of genetic alterations by inducing DNA double-stranded breaks 
(DSBs) that activate error-prone non-homologous end joining (NHEJ) or homology-
directed repair (HDR) at precise genomic positions (Figure 1; Liu et al., 2012). The 
adaptability of ZFNs and TALENs emerge from the capability to customize the DNA-
binding domain to recognize virtually any sequence (Carlson et al., 2012). These DNA-
binding modules can be merged with various effector domains, including repressors 
recombinases, transposases, nucleases, transcriptional activators, histone 
acetyltransferases and DNA-histone methyltransferases to influence the genomic 
structure and function (Gaj et al., 2013). Therefore, the capacity to modify a gene is  
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Figure 1. Nuclease-induced double-stranded breaks (DSBs) used for gene editing. 
The DSBs made in a genomic target site initiate DNA damage response pathways that 
repair the break either by non-homologous end joining (NHEJ), which result in indel 
mutations (red and green), or by homology-directed repair (HDR) in the presence of a 
repair template (blue), which lead to precise modification of the genome. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Biotechnology (Sander & Joung), 
copyright (2014). 
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largely based on the DNA-binding affinity and specificity of designed zinc-finger and 
TALE proteins. 
1.2.3 Recombinase-mediated cassette exchange  
Recombinase-mediated cassette exchange (RCME) is the exchange of two specific DNA 
segments between two DNA molecules. The bacteriophage ФC31 integrase is used to 
perform RMCE (Groth et al., 2004; Venken et al., 2011). The enzyme typically catalyzes 
specific, unidirectional, site-specific recombination between two attachment sites (att 
sites) called attP and attB. The ФC31 integrase facilitates recombination between the two 
39 base pair sequences, the attP site, which is usually pre-integrated into a Drosophila 
chromosome and serves as a target, or landing site, for precise integration of DNA carried 
on a plasmid with an attB site (Bischof et al., 2007). After recombination, the attP and 
attB sites are converted to attR and attL sites (Figure 2; Groth et al., 2004; Bateman et 
al., 2006). The incorporated or exchanged DNA is stably inherited and expressed. 
1.2.4 Clustered regularly interspaced short palindromic repeats   
Clustered regularly interspaced short palindromic repeats  (CRISPR) is a relatively recent 
and novel genome engineering tool that is being employed to accomplish efficient, 
targeted, genetic modifications not only in Drosophila, but also in the genomes of many 
other model and non-model organisms (Cho et al., 2013; Cong et al., 2013; DiCarlo et 
al., 2013; Friedland et al., 2013; Gratz et al., 2013; Hwang et al., 2013; Wang et al., 
2013). CRISPR was first discovered in 1987 in the Escherichia coli (E. coli) genome and 
has subsequently been shown to participate in adaptive bacterial immunity (Ishino et al., 
1987; Barrangou et al., 2007). The CRISPR/ Cas9 system protects prokaryotes against 
foreign genetic elements (Figure 3.A; Bhaya et al. 2011). In the type II CRISPR system 
short RNA sequences complementary to the invading nucleic acids, the CRISPR RNA 
(crRNA), and a trans-activating CRISPR RNA (tracrRNA) direct the CRISPR-associated 
nuclease (Cas9) to introduce site specific DSBs in the exogenous invading DNA (Bhaya 
et al. 2011; Gaj et al., 2013). 
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Figure 2. Site-specific integration via φC31 integrase-mediated cassette exchange. 
The ФC31 integrase typically catalyzes specific, unidirectional, site-specific 
recombination between the attP sites (yellow triangles), which are usually pre-integrated 
into a genomic site for precise integration of DNA carried on a plasmid with attB sites 
(orange triangles). After recombination, the attP and attB sites are converted to attR sites 
(red triangles) in the host, and attL sites (grey triangles) in the donor plasmid. 
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Figure 3. CRISPR/Cas9 system. The type II CRISPR system has been used as a highly 
efficient method for generating site-specific cleavage of double-stranded DNA. (A) 
CRISPR system in prokaryotes. Small fragments from invading DNA (called spacer) are 
incorporated between CRISPR arrays within the host genome, and separated by a short 
palindromic repeats. CRISPR arrays are then transcribed and transcripts produce crRNA, 
which now contain a sequence complementary to the foreign DNA (protospacer) and part 
of CRISPR repeats. TracrRNA hybridizes to the crRNA repeat region and complexes 
with the Cas9 nuclease to introduce site-specific double-stranded breaks next to the PAM 
sequence in the exogenous invading DNA (Bhaya et al. 2011; Gaj et al., 2013; Sander & 
Joung, 2014). (B) The modified CRISPR/Cas9 system only requires RNA-guided Cas9 
nuclease isolated from Streptococcus pyogenes, a synthetic chimeric RNA (chiRNA) or 
guide RNA (gRNA) containing both the crRNA and the tracrRNA (Jinek et al., 2012). 
Reprinted by permission from Macmillan Publishers Ltd: Nature Biotechnology (Sander 
& Joung), copyright (2014). 
 
 
	
  
(B) (A) 
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Recently, the type II CRISPR system has been used as a highly efficient method for 
generating site-specific cleavage of double-stranded DNA (Gratz et al., 2013). 
CRISPR/Cas9 system used is a modification of the original type II system. The modified 
system still uses an RNA- guided Cas9 nuclease isolated from Streptococcus pyogenes, 
but has introduced a synthetic chimeric RNA (chiRNA) containing both the crRNA and 
the tracrRNA (Figure 3.B; Jinek et al., 2012). This advance established a simple two-
component CRISPR system for genome editing, as it only requires a binary 
Cas9/chiRNA riboprotein to create site-specific DSBs in the host DNA. The target site 
recognition of CRISPR/Cas9 depends on the chiRNA that contains 20 bases of sequence 
complementary with the targeted genomic DNA sequence, and targets DNA in the 
genome for cleavage when it is followed by a protospacer adjacent motif (PAM) 
sequence, “NGG”. The 20-base chiRNA recognition sequence and the PAM sequence 
make the CRISPR system very specific because the chance that an identical sequence of 
greater than 20 bases occurs twice in a genome is low (Horn & Handler, 2005; Gratz et 
al., 2013). The DSBs made in a genomic target site initiate DNA damage response 
pathways that repair the break either by NHEJ, which is error-prone, or by HR in the 
presence of a repair template, which can lead to precise modification of the genome 
(Capecchi, 1989; Banga & Boyd, 1992; Rong & Golic, 2000; Gratz et al., 2013). 
TALENs and ZFNs are chimeric nucleases that induce DSBs (Bibikova et al., 2002). 
However, these methods are laborious, time consuming and and the specificity is 
mediated through proteins not complementary nucleotide sequences relative to the 
simpler CRISPR system (Huang et al., 2009; Gaj et al., 2013).  
1.3 Development of Drosophila melanogaster 
D. melanogaster has an average life span of 30 days. Development of an adult fly takes 
10 days in a complex life cycle composed of four major stages: embryonic, larval, pupal 
and adult. First, embryogenesis, the development of a larva from a fertilized egg, is 
composed of a number of sub-stages: syncytial blastoderm, cellular blastoderm, 
gastrulation, germband extension and germband retraction. Embryogenesis takes one day 
after which a first instar larva hatches. This larva eats, grows and molts to give the second 
instar larva, which grows and molts to give the third instar larva. The three larval stages 
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take around 4-5 days to complete. After this, the larva forms a pupal case, entering the 
pre-pupal and the pupal stages. In the pupal stage, the fly transforms from the larval form 
to an adult in a process called metamorphosis. Finally, a sexually reproductive, adult fly 
ecloses from the pupal case. 
1.4 Segmentation in Drosophila melanogaster 
The development of the fertilized D. melanogaster egg into a larva and then an adult fly 
depends on proper pattern formation along the anterior-posterior (A-P) axis. Much 
research has been done on body pattern formation in Drosophila, and these studies have 
shown that this pattern formation is controlled by the hierarchical interaction between 
specific set of genes: maternal-effect genes, gap genes, pair-rule genes, segment polarity 
genes and Homeotic selector (Hox) genes. These hierarchal interactions give rise to a 
segmented larva. Drosophila embryogenesis has two distinct segmental registers: the first 
register, functioning early during embryogenesis, is the fourteen parasegments which 
later during development is transformed to give rise to the second register, the 
larval/adult segments that are composed of the posterior of one parasegment and the 
anterior of the next (Figure 4.A; Nüsslein-Volhard & Wieschaus, 1980; Martinez-Arias 
& Lawrence, 1984). Anterior-posterior pattern formation is initiated by signals provided 
to the developing egg from the maternal genome during oogenesis. These signals are 
messenger RNA molecules transcribed from the maternal-effect genes of the maternal 
germ-line genome. These RNA signals are important for determining the polarity of the 
developing embryo. The mRNA of the maternal-effect gene bicoid (bcd) defines the 
anterior end of the embryo while the mRNA of nanos (nos) gene defines the posterior 
end. The maternal-effect proteins regulate the expression of the first zygotically 
expressed genes, known as gap genes. The gap genes are expressed in broad domains 
along the A-P axis, and divide the embryo into broad regions. Gap proteins regulate the 
transcription of the pair-rule genes. The pair-rule genes are expressed in seven stripes of 
cells. Two pair-rule genes are very important for segmentation: fushi tarazu (ftz) and 
even-skipped (eve). The pair-rule gene ftz is involved in the establishment of even-
numbered parasegments whereas eve defines the odd numbered parasegments (Maier et  
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Figure 4. Drosophila segments and parasegments. Two pair-rule genes are very 
important for segmentation. (A) During the cellular blastoderm stage, ftz establishes the 
even numbered parasegments; whereas, eve defines the odd numbered parasegments, and 
in doing so, ftz and eve form the first register, the fourteen parasegments, which later 
during development are transformed to give rise to the second segmental register the 
larval/adult segments that are composed of the posterior of one parasegment and the 
anterior of the next. (B) Once segments are established, Hox genes give identity to each 
segment, three head segments; Mandibular, Maxillary and Labial, the three thoracic 
segments; T1, T2 and T3. The eight abdominal segments (A1-A8). Reprinted by 
permission from Developmental Biology, by Gilbert, Scott F., 8th edition, Chapter 9, 
Sinauer Associates Inc.; 2006.  
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al., 1990), and in doing so, set up the parasegmental boundaries. The protein products of 
pair-rule genes regulate the transcription of the segment polarity genes, which are 
responsible for establishing the A-P axis of each segment of the embryo (Lawrence et al., 
1987; Carroll et al., 1988). Once segments are established, all segmentation genes (gap 
genes, pair-rule genes, segment polarity genes) interact to regulate the Homeotic (Hox) 
genes that give identity to each segment (Figure 4.B; Mcginnis & Krumlauf 1992). For 
example, the genes of the Antennapedia Complex (ANT-C) control the formation of the 
three head segments; Mandibular, Maxillary and Labial, and the three thoracic segments; 
T1, T2 and T3 (Struhl, 1982). The segmental identities of the remaining eight abdominal 
segments (A1-A8) are controlled by the genes of the Bithorax Complex (BX-C) (Lewis, 
1978; Martinez-Arias & Lawrence, 1984).  
1.5 Fushi tarazu  
Fushi tarazu (ftz) is one of the best studied genes in D. melanogaster. The ftz gene was 
originally isolated using positional cloning (Wiener et al., 1984).  The expression patterns 
of FTZ mRNA and FTZ protein have been investigated extensively (Hafen et al., 1984; 
Krause et al., 1988). FTZ is expressed in two different phases of D. melanogaster 
development. First, FTZ is expressed in seven stripes, during the syncytial and cellular 
blastoderm and gastrulation stages, where FTZ plays a role in regulating segmentation 
(Krause et al., 1988). The seven stripes of FTZ expressed at the cellular blastoderm stage 
correlate with the cell of the future even-numbered parasegments. The seven FTZ 
expression stripes that define the even-number parasegments are interspersed with seven 
stripes of EVE expression that define the complementary odd-numbered parasegments. 
The second stage of expression is later during neurogenesis during the germband 
extension stage of embryogenesis where ftz is expressed in specific neurons (aCC, pCC, 
RP1 and RP2) (Doe et al., 1988; Carroll & Scott, 1985). 
1.6 Fushi tarazu known protein domains  
The ftz gene of D. melanogaster is a Hox-derived gene located within ANT-C, on the 
right arm of the third chromosome (Wakimoto & Kaufman, 1981; Scott et al., 1983). 
FTZ has three known protein domains: The HD, the FTZ-F1 binding site, and the PEST 
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degradation sequence. The HD, which is a conserved DNA binding domain encoded by 
the 180 bp homeobox sequence, interacts with a specific DNA binding site (Laughon & 
Scott, 1984). The HD is composed of 60 amino acids (aa) (McGinnis et al., 1984) which 
fold into a compact domain consisting of three alpha helixes connected by short loops, 
with two of the helixes forming a helix-turn-helix. This type of structure found in many 
other DNA binding domains (Laughon & Scott, 1984; Schier & Gehring, 1992). The first 
two helices are parallel, while the third helix is perpendicular to the axes of the first two 
helices. The third helix is the one that makes specific amino acid base contacts with 
DNA. HD-containing proteins have various roles, which include cellular differentiation 
and maintenance of pluripotency (McGinnis et al., 1984). The FTZ-F1 domain was first 
identified as binding to the zebra element of the ftz promoter; this cis-acting DNA 
sequence is found upstream of the ftz transcriptional start site (Hiromi et al. 1985). The 
zebra elements are involved in the regulation of ftz expression in the pair-rule periodicity 
in the embryo formation (Ueda et al, 1990). FTZ-F1 is an orphan nuclear receptor that is 
a DNA-binding transcription factor, which is expressed throughout development (Yu et 
al., 1997). In addition to binding to zebra elements, FTZ-F1 also binds to the FTZ protein 
via the FTZ-F1 binding site (Ueda et al, 1990; Guichet et al., 1997; Yu et al., 1997; 
Schwartz et al., 2011).  The formation of a FTZ/FTZ-F1 complex is required for 
segmentation, and is the reason why segmentation is determined by a FTZ HD-
independent activity (Fitzpatrick et al., 1992). Lastly, the PEST degradation sequence is 
located between amino acids 207 to 218 in FTZ. The PEST region is rich in proline (P), 
glutamic acid (E), serine (S) and threonine (T), and plays a role in maintaining the 
stability of FTZ and also acts as a signal for its degradation (Kellerman et al., 1990). 
 The D. melanogaster ftz and Hox genes have evolved from a common ancestral gene 
which encodes a homeodomain (HD)-containing protein. During the evolution of D. 
melanogaster, ftz has acquired a non-homeotic function in segmentation (Alonso et al., 
2001; Heffer et al., 2013). This is believed to have occurred due to loss of the HOX-
specific interaction motif (YPWM), which is a common HOX interaction motif mediating 
the interaction with the HOX cofactor Extradenticle (EXD) (Heffer et al., 2013), and the 
gain of a new motif (LXXLL) that mediates interaction with another cofactor, FTZ-F1 
(Figure 5; Yussa et al., 2001; Schwartz et al., 2001; Löhr & Pick, 2005). FTZ-F1 is  
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Figure 5. Evolution of ftz in D. melanogaster. The gene ftz arose from a Hox gene that 
during evolution lost its homeotic function by losing the YPWM motif, and gained a 
segmentation function by gaining the LXXLL motif. The FTZ protein in D. melanogaster 
has two major domains: FTZ-F1 binding site that is required for ftz segmentation activity, 
and a DNA-binding HD that is required for CNS development. 
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required with FTZ for segmentation, as previous studies have shown that embryos 
lacking FTZ-F1 expression had a ftz phenotype (Figure 6; Guichet et al., 1997; Yu et al., 
1997). The FTZ protein has two distinct activities differentially required during 
development. The two FTZ activities are the HD-dependent and HD-independent FTZ 
activities. The HD-independent FTZ activity is required for FTZ function in 
segmentation, and regulating the expression of key segmentation genes such as increasing 
engrailed (en) and repressing wingless (wg) expression, respectively. The expression of 
en and wg in adjacent cells sets up the parasegmental boundary. The HD-dependent FTZ 
activity is proposed to be required for the accumulation of a high level of FTZ expression 
through early autoactivation of ftz via ftz enhancer (Schier & Gehring, 1992; Hyduk & 
Percival-Smith, 1996). Recently, HD-dependent FTZ activity has been investigated in 
more detail in the Central Nervous System (CNS). Studies of ftz have shown that the 
expression of the pair rule gene eve in RP2 neurons in the developing CNS requires the 
FTZ HD-dependent activity as these neurons grow abnormally in embryos that lack the 
FTZ HD-dependent activity (Doe et al., 1988; Heffer et al., 2013). 
1.7 Rationale and objectives 
Genetic analyses have shown that both the HD-dependent and HD-independent FTZ 
activities are somehow required for segmentation, but that the HD-independent FTZ 
activity, in specific situations, is sufficient for segmentation (Fitzpatrick et al., 1992). To 
reconcile the requirement of the HD dependent FTZ activity and the HD-independent 
FTZ activity for segmentation, a model was proposed by Hyduk and Percival-Smith 
(1996) (Figure 7), in which the two FTZ activities operate at different times during D. 
melanogaster development. During the first stage, the FTZ HD-dependent transcriptional 
activation occurs in the cellular blastoderm embryo, where the FTZ HD binds directly to 
ftz enhancer activating high levels of FTZ expression through autoactivation. Later, 
during gastrulation, the FTZ HD-independent transcriptional activity is required to 
activate ftz enhancer, express EN and to establish a FTZ dependent cuticle (Hyduk & 
Percival-Smith, 1996). My project aimed at testing this model further by showing 
intragenic complementation of two engineered ftz alleles. My goal is to establish an 
expression system for FTZ by modifying the ftz locus using the CRISPR/Cas9 system.  
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Figure 6. ftz phenotypes in D. melanogaster larval cuticle. (A) A wild type larva 
established all segments (T1, T2, T3, A1, A2, A3, A4, A5, A6, A7 and A8). The larval 
cuticle derived from ftz expression is the even-numbered parasegments (denticle belts of 
T2, A1, A3, A5 and A7), and the larval cuticle derived from eve expression is the odd-
numbered parasegments (denticle belts of T1, T3, A2, A4, A6 and A8). (B) ftz mutant 
phenotype where the embryo failed to form the even-numbered parasegments, the larva 
developed from cuticle derived from the odd-numbered parasegments (T1, T3, A2, A4, 
A6 and A8) Nüsslein-Volhard & Wieschaus, 1980; Martinez-Arias & Lawrence, 1984). 
Reprinted by permission from Elyse Burlingham, (Burlingham, 2012) 
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Figure 7. The model proposed by Hyduk and Percival-Smith (1996). The two FTZ 
activities operate at different times during D. melanogaster development. First to operate 
is the FTZ HD-dependent transcriptional activation in the cellular blastoderm embryo, 
where the FTZ HD binds directly to ftz enhancer activating high levels of FTZ expression 
through autoactivation. Later, during gastrulation, the FTZ HD-independent 
transcriptional activity is required to activate ftz enhancer, express EN and to establish 
FTZ dependent cuticle. Figure reproduced with permission of GENETICS SOCIETY OF 
AMERICA [ETC.] in the format Republish in a thesis/dissertation via Copyright 
Clearance Center.  
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First, I will modify the ftz locus such that the DNA will encode for three FTZ proteins: a 
full length- wild type FTZ (FTZFL), a FTZ polypeptide with a complete deletion of the 
HD (FTZΔHD), and a FTZ polypeptide with a deletion of FTZ-F1 binding site (FTZΔFTZ-
F1)  (Figure 8). Based on the model proposed by Hyduk and Percival-Smith, I expect ftzFL 
larvae to develop normally with all even numbered parasegments, because this locus 
expresses both HD-dependent and HD-independent FTZ activities. Larvae expressing 
ftzΔHD and ftzΔFTZ-F1 mutated genes will exhibit a ftz phenotype, because the ftzΔHD  allele 
can not express sufficient FTZ protein to establish segmentation, and the ftzΔFTZ-F1  allele 
lacks the HD-independent activity required for segmentation. However, to test the model 
that FTZ has two activities, embryos that are hemizygous for the ftzΔHD and ftzΔFTZ-F1 
alleles should result in intragenic complementation, where enough HD- independent FTZ 
activity is present to generate the wild type phenotype (Figure 9). 
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Figure 8. The structure of different FTZ proteins involved in this study. A full length 
FTZ (FTZFL), a FTZ polypeptide with a deletion of FTZ-HD (FTZΔHD ), a FTZ 
polypeptide with a deletion of the FTZ-F1 binding site (FTZΔFTZ-F1). 
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Figure 9. Intragenic complementation to test FTZ-HD requirement in segmentation. (A) Embryos expressing the ftzFL gene will 
develop normally since the protein product of ftzFL allele has both HD-dependent and independent FTZ activities. (B) The HD-
dependent FTZ activity is responsible for the accumulation of high-levels of FTZ via the ftz enhancer in the late cellular blastoderm 
stage. Therefore, ftzΔHD embryos express a low-level of FTZ HD-independent activity and fail to form the even numbered 
parasegments. The abnormal CNS development is due to the inability of FTZ HD-dependent activity to regulate EVE expression in 
RP2 neurons. (C) Since FTZ/FTZ-F1 interaction is required for segmentation, ftzΔFTZ-F1 embryos will show a ftz phenotype. (D) The 
intragenic complementation between ftzΔHD and ftzΔFTZ-F1 alleles will result in wild-type embryos. The protein product of ftzΔFTZ-F1 
allele has a FTZ HD-dependent activity, which activates the high-levels of FTZ expression from ftzΔHD allele. The allele that lacks the 
HD will then continue to activate EN, repress WG and establish the even numbered parasegments. 
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2 MATERIALS AND METHODS 
2.1 Construction of chiRNAs for CRISPR 
Two chiRNAs were designed to recognize a specific sequence near the 3’ donor and 5’ 
acceptor splicing sites of the ftz intron between ftz exon 1 and exon 2. CRISPR chiRNA 
requires 20 nt homology to recognize the complementary target sequence in the genome 
followed by the PAM sequence (NGG) (Figure 10). The 5’ phosphorylated primers 
(ordered from Invitrogen) encoding 20 nt complementary to the targets in ftz were 
designed (APPENDIX 1). The primers were annealed, and inserted into the cohesive 
ends generated by BbsI in pU6-BbsI-chiRNA vector (Gratz et al. 2013). Ligation of the 
vector and annealed fragments was carried out at 18°C using T4 DNA ligase (New 
England Biolabs) and the ligated mixture was transformed into subcloning-competent 
DH5α cells (Invitrogen). Ampicillin (Amp)-resistant colonies were selected on LB+100 
µg/ml Amp plates. A Mini Plasmid Kit (Geneaid) was used to isolate the plasmid DNA. 
Restriction digest with BbsI verified that the desired chiRNA-encoding plasmids were 
generated (due to loss of BbsI restriction site following ligation). The constructs were 
sent for sequencing analysis at the DNA Sequencing Facility at Robarts Research 
Institute, London, Ontario, Canada for further confirmation. Finally, a QIAfilter Plasmid 
Midi Kit (Qiagen) was used to isolate the plasmid at high concentrations for 
microinjection.   
2.2 Construction of repair vector for CRISPR 
The repair vector was designed to contain a 5’ and a 3’ homology sequence homologous 
to ftz, separated by a yellow+ (y+) body colour marker gene flanked by two inverted attP 
docking sites for Recombinase-mediated cassette exchange (RMCE). The repair vector 
was constructed by the ordered ligation of four DNA fragments, the 5’ and 3’ sequences 
of ftz exons flanked by attP sequence and which contained BsaI restriction sites, 
introduced during PCR amplification from Drosophila genomic DNA. Primers were used 
to amplify the yellow gene from NotI-digested MiMIC plasmid (GenBank: GU370067; 
Venken et al., 2011) and designed to add BsaI sites to each end. The 5’, 3’ sequences of  
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Figure 10. The site targeted in ftz by the 5’ chiRNA/Cas9 riboprotein. The efficient 
target recognition of CRISPR chiRNA to induce DSBs requires 20 nt to recognize its 
complementary target sequence in the genome (black letters) followed by PAM sequence 
NGG (blue underlined letters). 
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ftz and y+ (ordered from Invitrogen; APPENDIX 2) were generated by PCR from the 
appropriate template using a High Fidelity Platinum Taq Polymerase (Invitrogen). The 
DNA fragments were purified using EZ-10 Spin Column DNA Gel Extraction Kit (Bio 
Basic Canada Inc.). The fragments were digested with BsaI (New England Biolabs) to 
generate cohesive ends to ligate into the pFUS_A vector. The pFUS_A was also digested 
with the restriction endonuclease, BsaI and the 5’ phosphates removed with calf intestinal 
phosphatase. All fragments were ligated together in a single reaction using T4 DNA 
ligase (New England Biolabs) (Figure 11). Subcloning efficiency competent cells DH5α 
(Invitrogen) were transformed with the ligation mixture and selected on LB+100µg/ml 
Spectinomycin (Spec) plates that were spread with 40µl 8% Xgal and 40µl 200µM IPTG 
spread prior to plating. Digestion of pFUS_A with BsaI removes the LacZ gene, and 
therefore, white-colored Spec resistant colonies were screened for. White colonies were 
re-streaked on LB+100µg/ml Spec plates for verification, followed by colony PCR using 
primers that were designed to amplify the yellow marker gene (APPENDIX 3). The PCR 
product was run on a 1% agarose gel to verify the presence of the yellow gene fragment. 
A Mini Plasmid Kit (Geneaid) was used to isolate plasmid DNA from a white-colored 
single colony, the structure of the repair vector was verified by restriction enzyme 
analysis. Finally, a QIAfilter Plasmid Midi Kit (Qiagen) was used to isolate the plasmid 
at high concentrations for microinjection purposes.   
2.3 In vitro transcription of ftz and Fst chiRNAs for CRISPR 
Two chiRNAs were designed for targeting the ftz and Frost (Fst) genes. The forward 
primer of the chiRNAs was designed to contain ftz or Fst sequences and the T7 RNA 
polymerase promoter sequence. The first two bases of the 20 base genome target 
sequence always start with GG, which is required for T7 RNA polymerase, and followed 
by the PAM (NGG) sequence: 
(GAAATTAATACGACTCACTATAGGN18GTTTTAGAGCTAGAAATAGC), where 
GGN18 is either ftz or Fst sequence. One common reverse primer was designed to encode 
the remainder of the chiRNA 
(AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTAT  
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Figure 11. The structure of the repair vector for CRISPR. The repair vector contains 
the 5’ and 3’ sequences of ftz exons, separated by a y+ gene flanked by two attP docking 
sites. Primers were designed to add BsaI sites to each end. The 5’and 3’ sequences of ftz 
and y+ were generated by PCR technology each with the appropriate template using a 
High Fidelity Platinum Taq Polymerase. The fragments were then digested with BsaI to 
generate unique cohesive ends to ligate with the pFUS_A vector, which was also digested 
with the restriction endonuclease, BsaI. All fragments were ligated together in a single 
reaction. 
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TTTAACTTGCTATTTCTAGCTCTAAAAC) (Bassett et al, 2013). The two primers 
(ordered from Invitrogen) hybridized to one another and a DNA fragment was generated 
using PCR (Figure 12; APPENDIX 4). The DNA fragment was purified with QIAquick 
PCR Purification Kit (Qiagen). For in vitro transcription (IVT), 0.5 µg of PCR product 
was used for 50µl total volume reaction using Megascript T7 Kit (Ambion) and incubated 
overnight. ChiRNAs were purified by phenol chloroform extraction and ethanol 
precipitation. To avoid RNAse in solutions, MilliQ water, 3M sodium acetate pH=5.2 
and PBS were DEPC treated. Cas9 mRNA was obtained from Invitrogen. 
2.4 Design of ftz constructs for RMCE 
Four ftz constructs were designed for RMCE to create modified ftz loci in vivo. The 
ФC31 integrase catalyzes the integration between the attP sites at the ftz attP y+ attP locus, 
and the attB sites in the plasmids that contain DNA constructs encoding four FTZ 
proteins (FTZFL , FTZΔHD  , FTZΔFTZ-F1 and FTZTT) involved in this study (Figure 13). 
The ftz constructs were obtained from four ectopic expression constructs (obtained from 
the Percival-Smith Lab) by restriction digestion with NotI. The digests were separated by 
2% agarose gel electrophoresis, and the ftz DNA fragments isolated using Gel/PCR DNA 
fragments Extraction Kit (Geneaid). The isolated fragments were ligated to NotI-digested 
pBS-SK plasmid containing inverted attB sites, previously generated by Laura Garofalo 
(University of Western Ontario, Canada). Ligation was carried out at 18°C using T4 
DNA ligase (New England Biolabs) and the ligated fragment was transformed into 
subcloning efficiency competent cells DH5α (Invitrogen). Ampicillin resistant colonies 
were selected on LB+100 µg/ml Amp plates. Mini Plasmid Kit (Geneaid) was used to 
isolate plasmid DNA from a single colony and verified by restriction enzyme analysis. 
The constructs were sent for sequencing analysis at the DNA Sequencing Facility at 
Robarts Research Institute, London, Ontario, Canada for further confirmation. Finally, a 
QIAfilter Plasmid Midi Kit was used to isolate the plasmid at high concentrations for 
microinjection purposes.  
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Figure 12. The site targeted in ftz by the synthesized 3’ chiRNA. The first two bases of the genome target sequence always start 
with diguanine GG, which is required for precise initiation of the T7 promoter, and followed by the PAM NGG sequence. The two 
primers hybridize to one another and the DNA fragment generated by PCR used for in vitro transcription. The synthesized chiRNA 
directs Cas9 to recognize and cleave both DNA strands upstream PAM sequence NGG. 
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Figure 13. Schematic of RMCE via ФC31 integrase. The exchange of the pre-existing cassette ftz attP y+ attP with the new cassettes: 
ftz attB FL attB , ftz attB ΔFTZ-F1 attB , ftz attB ΔHD attB  and ftz attB FTZ TT attB ,is mediated by RMCE following injection of the ФC31 integrase and 
pBS-SK plasmids that contain ftz DNA flanking attB sites. After recombination between attP and attB sites, the cassette is integrated 
between attR sites to establish ftz fly lines: ftz attR FL attR , ftz attR ΔFTZ-F1 attR , ftz attR ΔHD attR  and ftz attR FTZ TT attR . 
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2.5 Fly strains 
The three fly strains used in this study were: y w, act-cas9 flies y1 M{Act5C-Cas9.P}ZH-
2A w* (stock number 54590)  and nos-cas9 flies with genotype y1 M{nos-Cas9.P}ZH-2A 
w* (stock number 54591). The fly stocks were obtained from the Bloomington 
Drosophila Stock Centre. 
2.6 Microinjection of embryos and screening for successful 
germ-line transformants 
Eggs were collected every 30 min after egg laying (AEL) on apple juice plates smeared 
with yeast paste to stimulate oogenesis. To dechorionate the embryos, 3% bleach was 
poured on the plate for 1 min. The embryos were washed off into a mesh basket and 
rinsed with tap water. Using a dissecting needle, the embryos were lined up on the edge 
of an agar strip in a specific anterior-posterior orientation.  The aligned embryos were 
picked up on double-sided tape adhered to a glass microscope slide. Embryos were dried 
under a hair dryer for 3.45-4.45 min (depending on the room temperature and humidity), 
and then covered with halocarbon oil. The glass slide was placed under the microscope in 
order to inject embryos at the posterior end with a glass needle that was filled with the 
appropriate injection mixture. The injected embryos expressing Cas9 (act-Cas9, nos-
Cas9), or not expressing Cas9 (y w), were kept at 18°C for 48 h, then moved to 25°C to 
hatch into larva and then an adult fly. The injected embryos that developed into adult flies 
(G0) were crossed with 3-4 virgin y w flies of the opposite sex to verify a successful 
germ-line transmission of the targeted modification, and the F1 progeny of each cross 
(from 50-100 flies) were carefully screened under a microscope for the desired marker 
phenotype (y+ or w+). 
DNA Injection mixture: 
For y w flies: 
500ng/µl  Cas9                                                   
250ng/µl  Each chiRNA 
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100ng/µl Repair template 
10%  Glycerol  
1X    PBS solution 
For Cas9 flies: 
250ng/µl  Each chiRNA 
500ng/µl  Repair template 
10%  Glycerol  
1X    PBS solution 
P-Element Injection mixture: 
400ng/µl  P-Element 
200ng/µl  Helper plasmid (Δ2-3wc) 
RNA Injection mixture: 
For y w flies: 
100ng/µl  Cas9 mRNA                                                  
500ng/µl Each chiRNA 
300ng/µl  Repair template 
10%  Glycerol  
1X    PBS solution 
For Cas9 flies: 
500ng/µl  Each chiRNA 
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300ng/µl Repair template 
10%  Glycerol  
1X    PBS solution 
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3 RESULTS 
The aim of the study was to create a model to test for the interaction of FTZ HD-
dependent and HD-independent activities. The overall goal was to generate site-specific 
mutant ftz alleles and then test these alleles for intragenic complementation. The creation 
of these alleles was attempted in a two-step protocol. First, CRISPR was used to induce 
DSBs and repaired with HR to establish a mutant ftz locus containing attP sites. Second, 
the attP sites would be used to introduce engineered ftz alleles into the ftz locus via the 
RMCE technique (Groth et al., 2004). 
3.1 Design of constructs for CRISPR/Cas9-mediated HR 
3.1.1 ChiRNAs for CRISPR 
In the CRISPR system, a riboprotein consisting of chiRNA and the Cas9 protein makes 
site-specific DSBs in DNA. In my studies, I used two methods to generate chiRNAs. The 
first method was to clone the target sequence into the unique BbsI site of pU6-BbsI-
chiRNA plasmid, which after injection into the Drosophila syncytial blastoderm embryo 
is transcribed to give the chiRNA. The sites targeted in ftz by these chiRNAs are 
indicated in (Figure 14.A). In the second method I injected the mRNA directly into 
syncytial blastoderm embryos. The synthetic chiRNAs were transcribed in vitro by T7 
RNA polymerase, which starts the transcription with diguanine (GG). For that reason, the 
target sequence must start with GG for initiation of transcription at the T7 promoter 
(Figure 14.B). The two chiRNAs plasmids for ftz, and the two in vitro transcribed 
chiRNAs for each ftz and Frost (Fst), a positive control, were designed and analyzed by 
BLAST to minimize the chance of off-target effects. The synthesized chiRNAs direct 
Cas9 to recognize and cleave both DNA strands upstream of the PAM sequence NGG of 
the 5’ end and 3’ end of ftz or Fst exons, stimulating the cellular DNA repair mechanism 
HDR to occur. 
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Exon 1 Exon 2
IntronFtz locus
5’...atatggccaccacaaacagccagagccactacagctacgccgacaacatga
acatgtacaacatgtatcacccccacagcctgccgcccacctactacgataattca
ggcagcaatgcctactatcagaacacctccaattatcagggctactatccccagga
gagttactcggagagctgctactactacaacaatcaggagcaggtgaccacccaga
ctgtaccgcccgtgcaacccaccaccccgccgcccaaggccaccaagcgcaaggcc
gaagatgatgctgcttccatcatcgccgccgtggaggagcgacccagcacactgag
ggctctgctcaccaatcccgtgaagaagctgaagtacacccccgactatttctaca
caaccgtcgagcaggtgaagaaggctcccgccgtaagcaccaaggtcaccgccagc
cccgctcccagctacgaccaagagtacgtgactgtgcccacgcccagcgcctccga
ggatgtcgactacttggacgtctactcgccccagtcgcagacgcagaagctgaaga
atggcgactttgccacccctccgccaaccacgcccacctctctgccgcccctcgaa
ggcatcagcacgccaccccaatcgccgggggagaaatcctcgtcagctgtcagcca
ggagatcaatcatcgaattgtgacagccccgaatggagccggcgatttcaattggt
cgcacatcgaggagactttggcatcaggtaggcatcacacacgattaacaacccct
aaaaatacactttgaaaatattgaaaatatgtttttgtatacatttttgatatttt
caaacaatacgcagttataaaactcattagctaacccattttttctttgcttatgc
ttacagattgcaaagactcgaaacgcacccgtcagacgtacacccgctaccagacc
ctggagctcgagaaggagttccacttcaatagatacatcacccggcgtcgtcgcat
cgatatcgccaatgccctgagcctgagcgaaaggcagatcaagatctggttccaaa
accgacgcatgaagtcgaagaaggatcgcacgctggacagctccccggagcactgt
ggtgccggctacaccgcgatgctgccgccactggaggccacaagcaccgccaccac
cggggcaccatcggtgccagtgcccatgtaccaccaccaccaaaccaccgccgcct
accccgcttacagccacagtcacagtcatggttatggcctgctcaatgattaccct
cagcagcagacccaccagcagtacgatgcctacccgcagcagtaccaacatcagtg
cagctaccagcaacatccacaggacctctaccatctgtcttgaggtccggc...3’  
(A) 
                  5’...ccaccacaaacagccagagccac...3’!
 
 
           5’...gacctctaccatctgtcttgagg...3’  
              5’...ccaattatcagggctactatccc...3’ 
 
 
              5’...ccaccagcagtacgatgcctacc...3’ 
(B) 
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Figure 14. The sites targeted in ftz by the 5’ and 3’ chiRNAs. The intron region 
between the two ftz exons with the sequences chosen for design of CRISPR chiRNAs to 
direct cleavage of both DNA strands by Cas9 nuclease are indicated in blue and yellow. 
(A) The targeted cut site of chiRNAs expressed from plasmid DNA (purple arrow). The 
chiRNA required 20 nt to recognize its complementary target sequence in the genome 
followed by PAM sequence NGG (highlighted in blue; PAM in red letters). (B) The 
targeted cut site of chiRNAs directly injected as RNA (purple arrow). The chosen 
sequence was selected following the principle: GGN18 found on the sense or anti-sense 
strand of the targeted gene (highlighted in yellow).  
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3.1.2 Repair Template for CRISPR 
The repair template promotes HDR after the generation of DSBs at a gene locus by 
CRISPR/Cas9 system (Carroll & Beumer, 2014). The repair template constructed 
contains 5’ and 3’ sequences to ftz exons (homology arms), y+ as a body marker flanked 
by two inverted attP ɸC31 recombination sites. Thus, the marker was used to identify 
transformants flies (ftz attP y+ attP), if the repair template was inserted between ftz exons by 
HR replacing ftz coding sequence. The double-stranded DNA (dsDNA) was assembled 
into the pFUS_A vector using an ordered assembly strategy. Restriction digests were 
used to confirm the structure of the repair template (Figure 15). 
3.2 Screens for germ-line transformants 
During injection of a syncytial blastoderm embryo at the posterior end, pole cells take up 
the repair template and express the chiRNA riboprotein.  I screened for insertion of the y+ 
gene as an indication that HR directed repair of a DSB had occurred. Many methods have 
been used to express the chiRNA/Cas9 riboprotein in syncytial blastoderm embryos. 
First, the chiRNA was transcribed from a plasmid with a U6 promoter or the chiRNA was 
transcribed in vitro and injected directly into the embryo. Second, the Cas9 protein was 
either translated from a mRNA transcribed from an injected plasmid, expressed from a 
transgene containing Cas9 expressed from an actin or nos promoter inserted into the 
genome, or translated from a Cas9 mRNA which was injected directly into the embryo. 
In order to establish a germ-line transformant ftz flies via CRISPR/Cas9 system, injection 
was performed into two fly strains. Flies not expressing Cas9 (y w) which required three 
CRISPR components to be injected into syncytial blastoderm embryos: the Cas9 and 
chiRNAs-encoding plasmids (for CRISPR DNA injection), or Cas9 and chiRNA mRNA 
(for CRISPR RNA injection) along with the ftz repair template. y w flies embryos were 
injected with CRISPR DNA components which resulted in 78 fertile flies but no 
transformants with y+ body colour were obtained when F1 progeny were screened (Table 
1). CRISPR RNA components were also injected into y w embryos of which 80 flies were 
fertile but again no transformants were obtained  (Table 2). The second fly strain used 
was Cas9 transgenic flies, expressing the Cas9 nuclease in the germ-line. In this strain, 
only two CRISPR components are required to be injected. For all injections the repair  
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Figure 15. Restriction enzyme analysis of the repair template. (A) Restriction enzyme 
digests confirmed the orientation of the structured repair template (isolated from three 
single white colonies). Resolution of the digest products by 1% agarose gel 
electrophoresis showed an expected pattern of cleavage using the restriction enzymes 
BglII (4913, 3989, 1068 bp), XbaI (9970) and EcoRI (7876, 2094). (B) Schematic 
indicates where the restriction enzymes BglII , XbaI and EcoRI make the cuts in the 
repair template. 
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Table 1. Screens for germ-line transformants after CRISPR DNA injection. 
Fly strain  DNA injection
Total of 
survivors
Fertile Sterile
Transformant
 fly
y w ftz 107 78 29 0
nos-Cas9
 or act-Cas9
ftz 122 92 30 0
Total= 229 170 59 0
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Table 2. Screens for germ-line transformants after CRISPR RNA injection. 
Fly strain  RNA injection
Total of 
survivors
Fertile Sterile
Transformant
 fly
y w ftz 133 80 53 0
nos-Cas9
 or act-Cas9
ftz 116 86 30 0
Total= 249 166 83 0
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DNA template was injected. In one set of injections chiRNA encoding plasmids were 
injected and out of 92 fertile flies no transformants were identified  (Table 1). In a second 
set of injections in vitro transcribed chiRNA was injected and out of 86 fertile flies no 
transformants were identified  (Table 2). When preparing the RNA, it is important to 
avoid RNAse contamination. Thus, 2µl of each CRISPR component were analysed by 
2% agarose gel electrophoresis before injection (Figure 16). The gel showed RNA 
degradation in the presence of two of ftz repair templates, therefore the RNAse-free 
template was used in injection.  
CRISPR DNA injections of Frost (Fst) have shown an efficiency rate of 10% in 
Drosophila (unpublished data of Dr. Anthony Percival-Smith). Frost is a gene that plays 
a role in Drosophila thermal tolerance (Colinet et al., 2010). To test RNA injection 
efficiency, CRISPR RNA injection was tested to modify Fst locus in Cas9-expressing or 
not expressing flies. The chiRNAs and Fst repair template with/without the Cas9 mRNA 
were injected into syncytial blastoderm embryos. However, none of the screened F1 
progeny yielded any transformant progeny with the w+ marker (Table 3). The Fst RNA 
injection mixture was also tested prior and post injection to ensure integrity (Figure 17). 
To test my injection efficiency further, y w embryos at the syncytial blastoderm stage 
were injected with two components: a P-element containing plasmid and a helper plasmid 
transposase source (Δ2-3wc). One transformant fly w+ was observed after screening 
through F1 progeny (Table 3), suggesting that the injection procedure being followed 
works, albeit with low efficiency. 
3.3 Survival and sterility for the various CRISPR 
approaches 
The low survival rates have been observed in Drosophila CRISPR studies (Bassett et al. 
2013; Gratz et al., 2014). The injected CRISPR components could be toxic to some 
degree, which might have resulted in a low survival rate in the range of 2.3-14% post- 
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Table 3. Screens for germ-line transformants after P-element and CRISPR injections used as a control. 
Total of Transformant
survivors  fly
P-element 106 70 36 1
CRISPR (Fst) 30 23 7 0
nos-Cas9
 or act-Cas9
CRISPR (Fst) 10 8 2 0
Total= 146 101 45 1
Viable Sterile
y w
Fly strain   Injection
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Figure 16. CRISPR RNA stability for ftz injection. CRISPR components used in RNA 
injection mixture were analysed by 2% agarose gel electrophoresis before injection to test 
RNA integrity. The gel showed that Cas9 mRNA was degraded in the presence of ftz 
repair templates (1) and (2) (blue circles). Therefore, ftz repair template (3) was used for 
CRISPR RNA injection. 
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Figure 17. CRISPR RNA stability for Fst injection. Fst Injection mixture was analysed 
by 2% agarose gel electrophoresis before and after injection. The gel showed that all 
CRISPR components were still present after 4 hours of injection. 
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injection reported in (Table 4 & Table 5). In addition, it has been reported that 5.6-
78.4% of the injected survivor flies were sterile which was also found in this study 
(Table 4 & Table 5; Bassett et al. 2013; Gratz et al., 2013; Sebo et al., 2014; Yu et al., 
2013; Ren et al., 2014). 
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Table 4. The average survival rate and sterility rate of CRISPR DNA injection. 
 
Fly strain DNA Injection 
Number of 
 injected embryos 
Number of  
 survivors 
Average of 
 survival 
rate 
Number of  
 sterile survivors 
Average of 
 sterility 
rate 
y w 
ftz  
double chiRNAs  
(5' and 3') 
852 63 
8.4% 29 27.1% 
ftz  
single chiRNA  
(5' or 3') 
464 44 
nos Cas9- 
or  
act-Cas9 
ftz  
double chiRNAs  
(5' and 3') 
3368 93 
2.3% 30 24.6% 
ftz  
single chiRNA  
(5' or 3') 
1600 29 
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Table 5. The average survival rate and sterility rate of CRISPR RNA injection. 
 
Fly 
strain 
RNA Injection 
Number of 
 injected embryos 
Number of 
  survivors 
Average of  
survival rate 
Number of  
 sterile survivors 
Average of 
 sterility rate 
y w 
ftz  
double chiRNAs  
(5' and 3') 
1028 56 
5.7% 53 39.8% 
ftz  
single chiRNA  
(5' or 3') 
1300 77 
Fst  
double chiRNAs  
(5' and 3') 
214 30 14.0% 7 23.3% 
nos 
Cas9- 
or  
act-Cas9 
ftz  
double chiRNAs  
(5' and 3') 
2074 114 
3.1% 30 25.9% 
ftz  
single chiRNA  
(5' or 3') 
272 2 
Fst  
double chiRNAs  
(5' and 3') 
246 10 4.1% 2 20.0% 
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4 Discussion 
4.1 Limitation of CRISPR/Cas9 technique 
CRISPR/Cas9 system is a relatively recent genome editing technique that has only been 
employed for the past three years to manipulate not only the Drosophila genome, but also 
the genomes of many other model and non-model organisms. CRISPR/Cas9 is a highly 
selective method to induce site-specific breaks in double-stranded DNA. CRISPR DSBs 
introduce small insertion and deletion (indels) by NHEJ repair mechanism at the site of 
the DSB, or allow specific genomic alteration by HDR pathway when an exogenous 
repair template is supplied (Bassett et al., 2013; Gratz et al., 2013; Kondo & Ueda, 2013; 
Sebo et al., 2014; Yu et al., 2013; Port et al., 2014). The germ-line transmission rate 
reported in a previous study when injection plasmids encoding Cas9 and chiRNA protein 
into Drosophila embryos to induce DSBs followed by NHEJ-mediated repair was 5.9% 
for the induction of indels (Gratz et al., 2013). However, a higher mutagenesis rate of 
around 80% was observed when injecting CRISPR RNA (Cas9 mRNA and chiRNA) into 
syncytial blastoderm Drosophila embryos (Bassett et al., 2013; Yu et al., 2013). The 
difference of mutagenesis efficiency between CRISPR DNA and RNA injections may be 
due to the higher expression levels of direct injection of Cas9 and chiRNA mRNA, 
compared to their expression from an injected plasmids DNA (Bassett & Liu, 2014). 
CRISPR studies also use an effective, but time-consuming method (Bassett & Liu, 2014) 
to achieve genetic modification by crossing two transgenic flies: one expressing Cas9 
using the nanos promoter, and another line expressing chiRNA driven through the U6 
promoter. This method achieved the highest mutagenesis with 90% of flies yielding a 
mutant offspring (Kondo & Ueda, 2013; Bassett & Liu, 2014). However, an alternative to 
this method with 12-75% efficiency, is to inject Cas9-expressing flies with chiRNA 
encoding plasmids (Ren et al., 2013; Sebo et al., 2014). 
CRISPR/Cas9 can be used to create precise genome modifications. The DSBs stimulate a 
HDR pathway in the presence of an exogenous template that shares a 20 nt homology 
  
45 
with the target DNA on either side of the break site. CRISPR/Cas9 potential to facilitate 
this integration is reported to be lower than induced mutations by NHEJ repair (Gratz et 
al., 2013; Gratz et al., 2014; Port et al., 2014). The injection of the three CRISPR 
components: Cas9 and chiRNA encoding DNA plasmids along with a repair template had 
yielded an integration efficiency of 0.3% (Gratz et al., 2013). Cas9-expressing flies 
showed an increase in integration between 0-11% (Gratz et al., 2014). This can be 
explained by fewer CRISPR components being injected, considering 11-38% of the 
offsprings integrated the exogenous template (Port et al., 2014) when introduced into 
Cas9 and chiRNA-expressing transgenic flies. 
The ability of CRISPR/Cas9 system to create DSBs at a specific target in the genome is 
solely dependent on the 20 nt homology of chiRNA, which guides the Cas9 nuclease to 
the target sequence. However, a 20 nt homology to the target sequence might not be good 
enough for proper targeting of Cas9 to the desired locus. A 20 nt homology length might 
increase the chances of creating off-target DSBs (Bassett & Liu, 2014). In this study, the 
failure to modify ftz loci by CRISPR/Cas9 system using HDR, could be explained by the 
low rate of integration observed in previous studies mentioned above. As a control for my 
injection technique, I was successful in establishing a germ-line transformant fly by the 
P-element mediated transformation technique, albeit at a low frequency. 
Furthermore, the stability of chiRNA in vivo can affect the efficiency of CRISPR/Cas9 
system. If chiRNAs are unstable due to some in vivo degradation mechanism, it would 
fail to direct the Cas9 to the target sequence. Accessibility to chromatin can be another 
factor that can interfere with the CRISPR/Ca9 system. Epigenetic mechanisms like 
methylation have been known to protect a sequence from being mutated (Gowher et al., 
2000; Takayama et al., 2014). Epigenetic silencing might be the case for Hox and derived 
Hox genes, which are crucial for the development of an organism. Thus, it remains to be 
determined whether Hox genes can at all be modified. 
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4.2 Alternative strategies 
To establish a germ-line transformant ftz fly, I attempted to inject syncytial blastoderm of 
y w and Cas9-expressing flies with both CRISPR DNA and RNA, but in all cases, no 
germ-line transformants were obtained (Table 1 & Table 2). An alternative experiment is 
to inject the repair template into fly embryos that express both Cas9 and chiRNA from 
transgenes. This would minimize the number of CRISPR components required to be 
injected, thus increasing the efficiency of the CRISPR system to create and repair DSBs 
(Port et al., 2014). 
There are no reports of CRISPR/Cas9-mediated editing of Hox genes in the literature. It 
has been shown that genes which could not be modified by CRISPR/Cas9 system, were 
successfully edited by TALENs (Treen et al. 2013; Sasaki et al. 2014). If CRISPR fails to 
edit/modify the Hox genes, which are indispensable for the proper development of the 
organism, this failure of CRISPR suggests that there might exist an inherent epigenetic 
mechanism, for instance, methylation, which protects these evolutionarily conserved 
genes from being mutated. 
4.3 Future / Expected results 
If a modified Drosophila with a manipulable ftz locus is generated and ftz constructs are 
reintroduced with RMCE, the initial goals of this project can then be pursued. The ftz 
locus that expresses wild type FTZFL should develop normally with all even numbered 
parasegments, as this locus expresses FTZ with both HD-dependent and HD-independent 
FTZ activities. ftz attR ftzΔHD attR larvae will exhibit a ftz phenotype because of an 
insufficient accumulation of FTZ protein due to the absence of the early transcriptional 
autoactivation of ftz via the ftz enhancer, which is HD-dependent. Subsequently, FTZ 
does not accumulate to a high level, such that the HD-independent activity of FTZ cannot 
rescue the formation of the even numbered parasegments. Also, embryos should have an 
abnormal nervous system, because the HD-dependent FTZ activity is required for 
nervous system development (Heffer et al., 2013). ftz attR ftzΔFTZ-F1 attR larvae will also have 
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a ftz phenotype due to the inability of FTZ ΔFTZF1 to regulate EN and WG expression, 
since the FTZ segmentation function requires the FTZ-F1 interaction, via the LXXLL 
motif (Schwartz et al., 2001). Furthermore, the nervous system should develop normally, 
since it requires the HD-dependent FTZ activity. To test the hypothesis that FTZ has two 
activities, we expect that establishment of flies that are hemizygous for the ftz attR ftzΔHD attR 
and  ftz attR ftzΔFTZ-F1 attR alleles should result in intragenic complementation, where a 
complementation occurs between two ftz mutant alleles, to give the wild type phenotype. 
This is because the ftz attR ftzΔFTZ-F1 attR allele, which has a HD-dependent FTZ activity, will 
be able to activate high levels of FTZ expression from the ftz attR ftzΔHD attR allele. The ftz 
attR ftzΔHD attR allele that encodes the HD-independent FTZ activity will activate the 
expression of EN, repress the expression of WG and establish the even numbered 
parasegments (Figure 9). Future studies using alternative genome editing strategies will 
hopefully allow the creation of novel models to test FTZ HD-dependent and HD-
independent functions. 
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                                       Appendices 
 
      List of Primers 
 
Appendix 1. Primers used for cloning ftz chiRNAs into pU6_BbsI_chiRNA plasmid 
Primer Sequence 
5' chiRNA-F 5'-...CTTCGACCTCTACCATCTGTCTTG…-3' 
5' chiRNA-R 5'-...AAACCAAGACAGATGGTAGAGGTC…-3' 
  
3' chiRNA-F 5'-...CTTCGTGGCTCTGGCTGTTTGTGG…-3' 
3' chiRNA-R 5'-...AAACCCACAAACAGCCAGAGCCAC…-3' 
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Appendix 2. Primers used for constructing the repair template 
Primer Sequence  PCR Template  
5' ftz-F 5'-...CAGCTAGGTCTCGCTATAGCATCCATAGACAACCTACTTAAA…-3' 
y w 
(Genomic DNA) 
5' ftz-R 
5'-...CAGCTAGGTCTCCCATGCCCCCAACTGAGAGAA 
CTCAAAGGTTACCCCAGTTGGGGCGGATGTGTATTGCTAGATTTC…-3' 
   
y+-F 5'-...CAGCTAGGTCTCCCATGCGACTATTAAATGATTATCGCC…-3' MiMIC 
(Venken et al., 
2011) y
+-R 5'-...CAGCTAGGTCTCGGTCCTCGACCTGCAGGTCAACGGATC…-3' 
   
3' ftz-F 
5'-...CAGCTAGGTCTCGGGACCCCCCAACTGAGAGAA 
CTCAAAGGTTACCCCAGTTGGGGGGTCCGGCGATGCTCAGTTAC…-3' y w 
(Genomic DNA) 
3' ftz-R 5'-...CAGCTAGGTCTCCCGCCCCAAAATGTGACATTTTCTCTGGCG…-3' 
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Appendix 3. Primers used for colony PCR screening of the correct repair template 
Primer Sequence  
Screen 1-F 5'-...CTGGCAGTTCCCTACTCTCG…-3' 
Screen 1-R 5'-...GGTAAATCAGCGGGCTGCGTTCG…-3' 
  
Screen 2-F 5'-...CAGGGAAAGTTCAACTTAATCGC…-3' 
Screen 2-R 5'-...CTGTCCTGGCTGGTCTAGACGTC…-3' 
  
Screen 3-F Same as (Screen 2-F) 
Screen 3-R 5'-...GAGCCGCCACCAATTGGACC…-3' 
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Appendix 4. Primers used to generate chiRNAs template for IVT 
Primer Sequence  
T7-ftz chiRNA1-F 
5'-...GAAATTAATACGACTCACTATAGGGATAGTAGCCCTGATAAT 
GTTTTAGAGCTAGAAATAGC…-3' 
T7-ftz chiRNA2-F 
5'-...GAAATTAATACGACTCACTATAGGTAGGCATCGTACTGCTGG 
GTTTTAGAGCTAGAAATAGC…-3' 
T7-Fst chiRNA1-F 
5'-...GAAATTAATACGACTCACTATAGGCGGTTGGTTCGGAAATTT 
GTTTTAGAGCTAGAAATAGC…-3' 
T7-Fst chiRNA2-F 
5'-...GAAATTAATACGACTCACTATAGGAGCCCCAACCGAACCTCC 
GTTTTAGAGCTAGAAATAGC…-3' 
Common primer-R 
5'-...AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAA 
CTTGCTATTTCTAGCTCTAAAAC…-3' 
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Copyright Permissions for Figures 
 
Appendix 5. Permission to use (figure 1 + figure 3) 
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Appendix 6. Permission to use (figure 4) 
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Appendix 7. Permission to use (figure 6) 
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Appendix 8. Permission to use (figure 7) 
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